[["index.html", "Open Science at Penn State Section 1 About", " Open Science at Penn State John Doe 2022-11-02 Section 1 About This is a research protocol for “Knowledge about and attitudes toward open science practices among Penn State researchers”, (STUDY00021455: Open science at Penn State) written in Markdown. "],["objectives.html", "Section 2 Objectives 2.1 Study Objectives 2.2 Primary Study Endpoints 2.3 Secondary Study Endpoints", " Section 2 Objectives 2.1 Study Objectives 2.2 Primary Study Endpoints 2.3 Secondary Study Endpoints "],["background.html", "Section 3 Background 3.1 Scientific Background and Gaps 3.2 Previous Data 3.3 Study Rationale", " Section 3 Background 3.1 Scientific Background and Gaps 3.2 Previous Data 3.3 Study Rationale "],["inclusion-and-exclusion-criteria.html", "Section 4 Inclusion and Exclusion Criteria 4.1 Inclusion Criteria 4.2 Exclusion Criteria 4.3 Early Withdrawal of Subjects", " Section 4 Inclusion and Exclusion Criteria 4.1 Inclusion Criteria 4.1.1 Does this research involve collecting data from individuals residing outside of the US? 4.2 Exclusion Criteria 4.3 Early Withdrawal of Subjects 4.3.1 Criteria for removal from study 4.3.2 Follow-up for withdrawn subjects "],["recruitment-methods.html", "Section 5 Recruitment Methods 5.1 Identification of subjects 5.2 Recruitment process", " Section 5 Recruitment Methods 5.1 Identification of subjects 5.2 Recruitment process 5.2.1 How potential subjects will be recruited 5.2.2 Where potential subjects will be recruited 5.2.3 When potential subjects will be recruited 5.2.4 Describe the eligibility screening process. Screening begins when the investigator obtains information about or from a prospective participant in order to determine their eligibility. "],["consent-process-and-documentation.html", "Section 6 Consent Process and Documentation 6.1 Consent Process 6.2 Obtaining Informed Consent 6.3 Waiver of Written Documentation of Consent 6.4 Informed consent will be sought but some of the elements of informed consent will be omitted or altered (e.g., deception). 6.5 Informed consent will not be obtained – request to completely waive the informed consent requirement 6.6 Consent – Other Considerations", " Section 6 Consent Process and Documentation 6.1 Consent Process 6.2 Obtaining Informed Consent 6.2.1 Consent Process 6.2.2 Coercion or Undue Influence during Consent 6.3 Waiver of Written Documentation of Consent 6.3.1 Indicate which of the following conditions applies to this research: 6.3.2 Indicate what materials, if any, will be used to inform potential subjects about the research (e.g., a letter accompanying a questionnaire, verbal script, or implied consent form). 6.4 Informed consent will be sought but some of the elements of informed consent will be omitted or altered (e.g., deception). 6.4.1 Indicate the elements of informed consent to be omitted or altered. 6.4.2 Indicate why the research could not practicably be carried out without the omission or alteration of consent elements 6.4.3 Describe why the research involves no more than minimal risk to subjects. 6.4.4 Describe why the alteration/omission will not adversely affect the rights and welfare of subjects. 6.4.5 If the research involves using identifiable private information or identifiable biospecimens, describe why the research could not practicably be carried out without using such information or biospecimens in an identifiable format. 6.4.6 Debriefing 6.5 Informed consent will not be obtained – request to completely waive the informed consent requirement 6.5.1 Indicate why the research could not practicably be carried out without the waiver of consent. 6.5.2 Describe why the research involves no more than minimal risk to subjects. 6.5.3 Describe why the alteration/omission will not adversely affect the rights and welfare of subjects. 6.5.4 If the research involves using identifiable private information or identifiable biospecimens, describe why the research could not practicably be carried out without using such information or biospecimens in an identifiable format. 6.5.5 Additional pertinent information after participation. 6.6 Consent – Other Considerations 6.6.1 Non-English-Speaking Subjects 6.6.2 Cognitively Impaired Adults 6.6.2.1 Capability of Providing Consent 6.6.2.2 Adults Unable to Consent 6.6.2.3 Assent of Adults Unable to Consent 6.6.3 Subjects who are not yet adults (infants, children, teenagers) 6.6.3.1 Parental Permission 6.6.3.2 Assent of subjects who are not yet adults "],["hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html", "Section 7 HIPAA Research Authorization and/or Waiver or Alteration of Authorization 7.1 Authorization and/or Waiver or Alteration of Authorization for the Uses and Disclosures of PHI 7.2 Waiver or Alteration of Authorization for the Uses and Disclosures of PHI 7.3 Waiver or alteration of authorization statements of agreement", " Section 7 HIPAA Research Authorization and/or Waiver or Alteration of Authorization 7.1 Authorization and/or Waiver or Alteration of Authorization for the Uses and Disclosures of PHI 7.2 Waiver or Alteration of Authorization for the Uses and Disclosures of PHI 7.2.1 Access, use or disclosure of PHI representing no more than a minimal risk to the privacy of the individual 7.2.1.1 Plan to protect PHI from improper use or disclosure 7.2.1.2 Plan to destroy identifiers or a justification for retaining identifiers 7.2.2 Explanation for why the research could not practicably be conducted without access to and use of PHI 7.2.3 Explanation for why the research could not practicably be conducted without the waiver or alteration of authorization 7.3 Waiver or alteration of authorization statements of agreement "],["study-design-and-procedures.html", "Section 8 Study Design and Procedures 8.1 Study Design 8.2 Study Procedures 8.3 Duration of Participation", " Section 8 Study Design and Procedures 8.1 Study Design 8.2 Study Procedures 8.2.1 Visit 1 or Day 1 or Pre-test, etc. 8.2.2 Visit 2 or Day 2 or Post-test, etc. (If applicable) 8.3 Duration of Participation "],["number-of-subjects-and-statistical-plan.html", "Section 9 Number of Subjects and Statistical Plan 9.1 Number of Subjects 9.2 Sample Size Determination 9.3 Statistical or Analytic Methods", " Section 9 Number of Subjects and Statistical Plan 9.1 Number of Subjects 9.2 Sample Size Determination 9.3 Statistical or Analytic Methods "],["data-and-safety-monitoring-plan.html", "Section 10 Data and Safety Monitoring Plan 10.1 Periodic evaluation of data 10.2 Data that are reviewed 10.3 Method of collection of safety information 10.4 Frequency of data collection 10.5 Individuals reviewing the data 10.6 Frequency of review of cumulative data 10.7 Statistical tests 10.8 Suspension of research", " Section 10 Data and Safety Monitoring Plan 10.1 Periodic evaluation of data 10.2 Data that are reviewed 10.3 Method of collection of safety information 10.4 Frequency of data collection 10.5 Individuals reviewing the data 10.6 Frequency of review of cumulative data 10.7 Statistical tests 10.8 Suspension of research "],["risks.html", "Section 11 Risks", " Section 11 Risks List the reasonably foreseeable risks, discomforts, hazards, or inconveniences to the subjects related the subjects’ participation in the research. Include as may be useful for the IRB’s consideration, a description of the probability, magnitude, duration, and reversibility of the risks. Consider all types of risk including physical, psychological, social, legal, and economic risks. Note: Loss of confidentiality is a potential risk when conducting human subject research and must be listed here. - If applicable, indicate which procedures may have risks to the subjects that are currently unforeseeable. - If applicable, indicate which procedures may have risks to an embryo or fetus should the subject be or become pregnant. - If applicable, describe risks to others who are not subjects. "],["potential-benefits-to-subjects-and-others.html", "Section 12 Potential Benefits to Subjects and Others 12.1 Potential Benefits to Subjects 12.2 Potential Benefits to Others", " Section 12 Potential Benefits to Subjects and Others 12.1 Potential Benefits to Subjects 12.2 Potential Benefits to Others "],["sharing-results-with-subjects.html", "Section 13 Sharing Results with Subjects", " Section 13 Sharing Results with Subjects Describe whether results (study results or individual subject results, such as results of investigational diagnostic tests, genetic tests, or incidental findings) will be shared with subjects or others (e.g., the subject’s primary care physicians) and if so, describe how information will be shared. "],["subject-payment-andor-travel-reimbursements.html", "Section 14 Subject Payment and/or Travel Reimbursements", " Section 14 Subject Payment and/or Travel Reimbursements Describe the amount, type (cash, check, gift card, other) and timing of any subject payment or travel reimbursement. If there is no subject payment or travel reimbursement, indicate as not applicable. Extra or Course Credit: Describe the amount of credit and the available alternatives. Alternatives should be equal in time and effort to the amount of course or extra credit offered. It is not acceptable to indicate that the amount of credit is to be determined or at the discretion of the instructor of the course. Approved Subject Pool: Indicate which approved subject pool will be used; include in response below that course credit will be given and alternatives will be offered as per the approved subject pool procedures. "],["economic-burden-to-subjects.html", "Section 15 Economic Burden to Subjects 15.1 Costs 15.2 Compensation for research-related injury", " Section 15 Economic Burden to Subjects 15.1 Costs Describe any costs that subjects may be responsible for because of participation in the research. Not applicable 15.2 Compensation for research-related injury If the research involves more than Minimal Risk to subjects, describe the available compensation in the event of research related injury. If there is no sponsor agreement that addresses compensation for medical care for research subjects with a research-related injury, include the following text as written - DO NOT ALTER OR DELETE: It is the policy of the institution to provide neither financial compensation nor free medical treatment for research-related injury. In the event of injury resulting from this research, medical treatment is available but will be provided at the usual charge. Costs for the treatment of research-related injuries will be charged to subjects or their insurance carriers. For sponsored research studies with a research agreement with the sponsor that addresses compensation for medical care for research-related injuries, include the following text as written - DO NOT ALTER OR DELETE: It is the policy of the institution to provide neither financial compensation nor free medical treatment for research-related injury. In the event of injury resulting from this research, medical treatment is available but will be provided at the usual charge. Such charges may be paid by the study sponsor as outlined in the research agreement and explained in the consent form. Not applicable. "],["resources-available.html", "Section 16 Resources Available 16.1 Facilities and locations 16.2 Feasibility of recruiting the required number of subjects 16.3 PI Time devoted to conducting the research 16.4 Availability of medical or psychological resources 16.5 Process for informing Study Team", " Section 16 Resources Available 16.1 Facilities and locations Identify and describe the facilities, sites, and locations where recruitment and study procedures will be performed. If research will be conducted outside the United States, describe site-specific regulations or customs affecting the research, and describe the process for obtaining local ethical review. Also, describe the principal investigator’s experience conducting research at these locations and familiarity with local culture. \\[Type protocol text here\\] 16.2 Feasibility of recruiting the required number of subjects Indicate the number of potential subjects to which the study team has access. Indicate the percentage of those potential subjects needed for recruitment. \\[Type protocol text here\\] 16.3 PI Time devoted to conducting the research Describe how the PI will ensure that a sufficient amount of time will be devoted to conducting and completing the research. Consider outside responsibilities as well as other on-going research for which the PI is responsible. Please only provide a response for the principal investigator – do not include information about any other study team members. \\[Type protocol text here\\] 16.4 Availability of medical or psychological resources Describe the availability of medical or psychological resources that subjects might need as a result of their participation in the study. \\[Type protocol text here or indicate as not applicable\\] 16.5 Process for informing Study Team Describe the training plans to ensure members of the research team are informed about the protocol and their duties. \\[Type protocol text here or indicate as not applicable if the principal investigator is the only study team member listed on the CATS IRB submission\\] "],["other-approvals.html", "Section 17 Other Approvals 17.1 Other Approvals from External Entities 17.2 Internal PSU Ancillary Reviews", " Section 17 Other Approvals 17.1 Other Approvals from External Entities Describe any approvals that will be obtained prior to commencing the research (e.g., from engaged cooperating institutions IRBs who are also reviewing the research and other required review committees, community leaders, schools, research locations where research is to be conducted by the Penn State investigator, funding agencies, etc.). Not applicable 17.2 Internal PSU Ancillary Reviews DO NOT ALTER OR DELETE: Ancillary reviews are reviewed by other compliance groups or individuals within Penn State that inform the IRB’s review of a new study or a modification to an existing study. PSU IRB may set applicable ancillary reviews for your study. Please refer to the “HRP-309 Worksheet – Ancillary Review Matrix” for more information (found in the CATS Library). "],["multi-site-study.html", "Section 18 Multi-Site Study 18.1 If this is a multi-site study (i.e., a study in which two or more institutions coordinate, with each institution completing all research activities outlined in a specific protocol) and the Penn State PI is the lead investigator, describe the processes to ensure communication among sites in the sections below. 18.2 Other sites 18.3 Communication Plans 18.4 Data Submission and Security Plan 18.5 Subject Enrollment 18.6 Reporting of Adverse Events and New Information 18.7 Audit and Monitoring Plans", " Section 18 Multi-Site Study 18.1 If this is a multi-site study (i.e., a study in which two or more institutions coordinate, with each institution completing all research activities outlined in a specific protocol) and the Penn State PI is the lead investigator, describe the processes to ensure communication among sites in the sections below. 18.2 Other sites List the name and location of all other participating sites. Provide the name, qualifications and contact information for the principal investigator at each site and indicate which IRB will be reviewing the study at each site. \\[Type protocol text here or indicate as not applicable\\] 18.3 Communication Plans Describe the plan for regular communication between the overall study director and the other sites to ensure that all sites have the most current version of the protocol, consent document, etc. Describe the process to ensure all modifications have been communicated to sites. Describe the process to ensure that all required approvals have been obtained at each site (including approval by the site’s IRB of record). Describe the process for communication of problems with the research, interim results, and closure of the study. \\[Type protocol text here or indicate as not applicable\\] 18.4 Data Submission and Security Plan Describe the process and schedule for data submission and provide the data security plan for data collected from other sites. Describe the process to ensure all engaged participating sites will safeguard data as required by local information security policies. \\[Type protocol text here or indicate as not applicable\\] 18.5 Subject Enrollment Describe the procedures for coordination of subject enrollment and randomization for the overall project. \\[Type protocol text here or indicate as not applicable\\] 18.6 Reporting of Adverse Events and New Information Describe how adverse events and other information will be reported from the clinical sites to the overall study director. Provide the timeframe for this reporting. \\[Type protocol text here or indicate as not applicable\\] 18.7 Audit and Monitoring Plans Describe the process to ensure all local site investigators conduct the study appropriately. Describe any on-site auditing and monitoring plans for the study. \\[Type protocol text here or indicate as not applicable\\] "],["adverse-event-reporting.html", "Section 19 Adverse Event Reporting 19.1 Reporting Adverse Reactions and Unanticipated Problems to the Responsible IRB", " Section 19 Adverse Event Reporting 19.1 Reporting Adverse Reactions and Unanticipated Problems to the Responsible IRB By submitting this study for review, you agree to the following statement – DO NOT ALTER OR DELETE: In accordance with applicable policies of The Pennsylvania State University Institutional Review Board (IRB), the investigator will report, to the IRB, any observed or reported harm (adverse event) experienced by a subject or other individual, which in the opinion of the investigator is determined to be (1) unexpected; and (2) probably related to the research procedures. Harms (adverse events) will be submitted to the IRB in accordance with the IRB policies and procedures. "],["study-monitoring-auditing-and-inspecting.html", "Section 20 Study Monitoring, Auditing, and Inspecting 20.1 Auditing and Inspecting", " Section 20 Study Monitoring, Auditing, and Inspecting 20.1 Auditing and Inspecting By submitting this study for review, you agree to the following statement – DO NOT ALTER OR DELETE: The investigator will permit study-related monitoring, audits, and inspections by the Penn State quality assurance program office(s), IRB, the sponsor, and government regulatory bodies, of all study related documents (e.g., source documents, regulatory documents, data collection instruments, study data etc.). The investigator will ensure the capability for inspections of applicable study-related facilities (e.g., pharmacy, diagnostic laboratory, etc.). "],["future-undetermined-research-data-and-specimen-banking.html", "Section 21 Future Undetermined Research: Data and Specimen Banking 21.1 Data and/or specimens being stored 21.2 Identify what data and/or specimens will be stored, and the data associated with each specimen. 21.3 Location of storage 21.4 Duration of storage 21.5 Access to data and/or specimens 21.6 \\[Type protocol text here or indicate as not applicable\\] 21.7 Procedures to release data or specimens 21.8 Process for returning results", " Section 21 Future Undetermined Research: Data and Specimen Banking If this study is collecting identifiable data and/or specimens that will be banked for future undetermined research, please describe this process in the sections below. This information should not conflict with information provided in section 22 below OR the “HRP-598 – Research Data Plan Review Form” regarding whether or not data and/or specimens will be associated with identifiers (directly or indirectly). If there are no plans to use identifiable data/specimens for future, undetermined research, then this section is NOT applicable. 21.1 Data and/or specimens being stored 21.2 Identify what data and/or specimens will be stored, and the data associated with each specimen. \\[Type protocol text here or indicate as not applicable\\] 21.3 Location of storage Identify the location where the data and/or specimens will be stored. \\[Type protocol text here or indicate as not applicable\\] 21.4 Duration of storage Identify how long the data and/or specimens will be stored. If data and/or specimens will be stored indefinitely, indicate such. \\[Type protocol text here or indicate as not applicable\\] 21.5 Access to data and/or specimens Identify who will have access to the data and/or specimens. 21.6 \\[Type protocol text here or indicate as not applicable\\] 21.7 Procedures to release data or specimens Describe the procedures to release the data and/or specimens, including: the process to request a release, approvals required for release, who can obtain data and/or specimens, and the data to be provided with the specimens. \\[Type protocol text here or indicate as not applicable\\] 21.8 Process for returning results Describe the process for returning results about the use of the data and/or specimens. \\[Type protocol text here or indicate as not applicable\\] "],["references.html", "Section 22 References", " Section 22 References List relevant references in the literature which highlight methods, controversies, and study outcomes. \\[Type protocol text here or indicate as not applicable\\] "],["confidentiality-privacy-and-data-management.html", "Section 23 Confidentiality, Privacy and Data Management 23.1 Which of the following identifiers will be recorded for the research project? Check all that apply. If none of the following identifiers will be recorded, do not check any of the boxes. 23.2 If storing paper records of research data, answer the following questions: 23.3 If storing electronic records of research data, indicate where the electronic data associated with this research study will be stored. Check all that apply. 23.4 Is there a list/key that links code numbers to identifiers? 23.5 Is there a list of people who have access to the list/key? 23.6 Describe the mechanism in place to ensure only approved research personnel have access to the stored research data (electronic and paper). 23.7 Will research data be stored on a mobile device, such as an electronic tablet/cell phone or will research data be collected on a wireless activity tracker? 23.8 Will any research data be directly entered/sent by subjects over the internet or via email (e.g., data capture using on-line surveys/questionnaires, surveys via email, observation of chat rooms or blogs)? 23.9 Will any type of recordings (e.g., audio or video) or photographs of the subjects be made during this study? 23.10 Certificate of Confidentiality (COC) - Is the research biomedical, behavioral, clinical or other research that is funded by the National Institutes of Health (NIH)? 23.11 What steps will be taken to protect subjects’ privacy interests? (Check all that apply.) 23.12 What is the process for ensuring correctness of data entry? 23.13 Does this research involve the generation of large-scale human genomic data as defined in NIH Genomic Data Sharing Policy (http://gds.nih.gov)? 23.14 Does this research involve transfer or disclosure of data and/or specimens to and/or from Penn State?", " Section 23 Confidentiality, Privacy and Data Management IMPORTANT: The following section is required for all locations EXCEPT Penn State Health and the College of Medicine. Penn State Health and College of Medicine should skip this section and complete “HRP-598 Research Data Plan Review Form.” In order to avoid redundancy, for this section state “See the Research Data Plan Review Form” if you are conducting Penn State Health research. Delete all other sub-sections of section 22. For research being conducted at Penn State Health or by Penn State Health researchers only: The research data security and integrity plan is submitted using “HRP-598 – Research Data Plan Review Form.” In order to avoid redundancy, for this section state “See the Research Data Plan Review Form” if you are conducting Penn State Health research. Delete all sub-sections of section 22. For all other research: Complete the following section. Please refer to PSU Policy AD95 for information regarding information classification and security standards and requirements. It is recommended that you work with local IT staff when planning to store, process, or access data electronically to ensure that your plan can be carried out locally and meets applicable requirements. If you have questions about Penn State’s Policy AD95 or standards or need a consultation regarding data security, please contact Penn State IT – Information Security at security@psu.edu. 23.1 Which of the following identifiers will be recorded for the research project? Check all that apply. If none of the following identifiers will be recorded, do not check any of the boxes. H ard C opy D ata Elect ronic S tored Data Names and/or initials (including on signed consent documents) All geographic subdivisions smaller than a State, including street address, city, county, precinct, zip code, and their equivalent geocodes, All elements of dates (except year) for dates directly related to an individual, including birth date, admission date, discharge date, date of death; and all ages over 89 and all elements of dates (including year) indicative of such age, except that such ages and elements may be aggregated into a single category of age 90 or older Telephone numbers Fax numbers Electronic mail addresses Social security numbers Medical record numbers Health plan beneficiary numbers Account numbers Certificate/license numbers Vehicle identifiers and serial numbers, including license plate numbers Device identifiers and serial numbers Web Universal Resource Locators (URLs) Internet Protocol (IP) address numbers Biometric identifiers, including finger and voice prints Full face photographic images and any comparable images Any other unique identifying number, characteristic, or code (such as the pathology number) Study code number with linking list Genomic sequence data State ID numbers Passport numbers Driver’s license numbers 23.2 If storing paper records of research data, answer the following questions: 23.2.1 23.2.2 Where will the paper records, including copies of signed consent forms, associated with this research study will be stored? \\[Type protocol text here or indicate as not applicable\\] 23.2.3 How will the paper records be secured? \\[Type protocol text here or indicate as not applicable\\] 23.2.4 How will access to the paper records be restricted to authorized project personnel? \\[Type protocol text here or indicate as not applicable\\] 23.3 If storing electronic records of research data, indicate where the electronic data associated with this research study will be stored. Check all that apply. Penn State-provided database application. Check which of the following database applications are being used (check all that apply): Penn State REDCap Other – Specify - provided and approved database application: \\[Type protocol text here if box checked\\] Penn State, College, or Department IT file server Penn State OneDrive or SharePoint Penn State GoogleDrive Web-based system provided by the sponsor or cooperative group - Specify URL and contact information: \\[Type protocol text here if box checked\\] Other – Specify the database application or server: \\[Type protocol text here if box checked\\] Provide details about the data security features or attach security documentation provided by sponsor or group: \\[Type protocol text here if box checked\\] Please visit datastoragefinder.psu.edu for assistance with identifying appropriate data storage options. If the software to be used does not appear on that site, a software request form must be completed. If there is a list/key that links indirect identifiers (code numbers, participant IDs, etc.) to direct identifiers, that list must not be comingled (i.e., stored in the same location) as the identifiable data, including copies of signed informed consent forms. Additionally, access to that list/key must be restricted to authorized project personnel. 23.4 Is there a list/key that links code numbers to identifiers? Yes - explain how the list that links the code to identifiers is stored separately from coded data: \\[Type protocol text here if box is checked\\] Not applicable, there is no list that links code numbers to identifiers. Skip to section 22.6. 23.5 Is there a list of people who have access to the list/key? Yes – explain how access to that list is restricted and why certain persons require access. \\[Type protocol text here if box is checked\\] No – explain why not: \\[Type protocol text here if box is checked\\] 23.6 Describe the mechanism in place to ensure only approved research personnel have access to the stored research data (electronic and paper). Password-protected files Role-based security Specify all other mechanisms used to ensure only permitted users have access to the stored research data: \\[Type protocol text here if box is checked\\] The use of mobile devices or wireless activity trackers to collect identifiable research data may have to be approved by Penn State IT - Information Security. 23.7 Will research data be stored on a mobile device, such as an electronic tablet/cell phone or will research data be collected on a wireless activity tracker? No – skip to 22.8 Yes - answer the following questions: 23.7.1 Specify the provider of the tracker or mobile devices(s) Supplied by the sponsor Penn State owned device A personal device Other – Please specify source: \\[Type protocol text here if box is checked\\] Specify the type(s) of tracker or mobile device(s) that will be used to capture data and all identifiers captured on the mobile device(s). Please list all devices, and if more than one, the identifiers to be collected on each. \\[Type protocol text here\\] 23.7.2 Specify the type of data collected on the tracker or mobile devices(s). \\[Type protocol text here\\] 23.7.3 Specify the application or website used to collect the data from the tracker or mobile device, if applicable. \\[Type protocol text here\\] Describe the measures taken to protect the confidentiality of the data collected on the tracker or mobile device(s). Please address physical security of the device(s), electronic security, and secure transfer of data from device(s) to the previously indicated data/file storage location provided in section 22.3. \\[Type protocol text here\\] Specify the The use of online survey tools and email to collect or send research data containing identifiers that represent more than minimal risk to subjects may have to be approved by Penn State IT - Information Security. 23.8 Will any research data be directly entered/sent by subjects over the internet or via email (e.g., data capture using on-line surveys/questionnaires, surveys via email, observation of chat rooms or blogs)? No – skip to 22.9 Yes - answer the following questions: 23.8.1 Specify the identifiers collected over the internet or via email (Including IP addresses if IP addresses will be collected). \\[Type protocol text here\\] 23.8.2 Specify the type of data collected over the internet or via email. \\[Type protocol text here\\] 23.8.3 Describe the measures taken to protect the confidentiality of the data collected? \\[Type protocol text here\\] 23.8.4 Describe how the research team will access the data once data collection is complete. \\[Type protocol text here\\] 23.8.5 If the research involves online surveys, list the name(s) of the service provider(s) that will be used for the survey(s) (e.g., REDCap, Penn State licensed Qualtrics, Survey Monkey, Zoomerang)? (Note: The IRB strongly recommends the use of REDCap for online surveys that obtain sensitive identifiable human subjects data.) Penn State REDCap Penn State Qualtrics Penn State Microsoft Forms Penn State Google Forms Other - Please specify: Application: \\[Type protocol text here\\] URL (If applicable): \\[Type protocol text here\\] 23.8.6 If the answer above is “Other” contact security@psu.edu for approval of an alternative data capture method \\[Type protocol text here\\] Depending on the nature of the subject matter involved, certain security requirements must be in place for the audio and/or video recording or photographing of subjects. If the subject matter presents more than minimal risk to the subjects, then, before completing the section below, please contact Penn State IT - Information Security at security@psu.edu to confirm whether these requirements are required. Specify the 23.9 Will any type of recordings (e.g., audio or video) or photographs of the subjects be made during this study? No - skip to section 22.10 Yes - answer the following questions: 23.9.1 What will be used to capture the audio/video/images? Give a brief description of content. Audio – Describe the intended content of the audio recording: \\[Type protocol text here\\] Video – Describe the intended content of the video recording: \\[Type protocol text here\\] Photographs of the subjects – Describe the intended content of the photographs: \\[Type protocol text here\\] 3-D Images – Describe the intended content of the of 3-D images: \\[Type protocol text here\\] Other - Specify: \\[Type protocol text here\\] 23.9.2 How will the recordings/photographs/images be stored (electronically or physically)? \\[Type protocol text here\\] 23.9.3 Where will the recordings/photographs/images be stored? \\[Type protocol text here\\] 23.9.4 Who will have access to the recordings/photographs/images? \\[Type protocol text here\\] 23.9.5 Will any of the recordings be transcribed? Not applicable No Yes – indicate who will be doing the transcribing? \\[Type protocol text here\\] 23.9.6 Will the recordings/photographs be used for purposes other than this research study? No Yes - specify purpose(s) (e.g., publication, presentations, educational training, future undetermined research): \\[Type protocol text here\\] What type of r 23.10 Certificate of Confidentiality (COC) - Is the research biomedical, behavioral, clinical or other research that is funded by the National Institutes of Health (NIH)? Yes - check one of the following: The research involves human subjects as defined by the DHHS regulations (See Worksheet HRP-310). The research involves collecting or using biospecimens that are identifiable to an individual. If collecting or using biospecimens as part of the research, there is a small risk that some combination of the biospecimen, a request for the biospecimen, and other available data sources could be used to deduce the identity of an individual. The research involves the generation of individual level, human genomic data. Note: If any of the 4 items above are checked, a COC is automatically issued by NIH and applies to the research. Information about the COC must be included in the consent form. No - answer the following question. If the research is not funded by NIH, will the investigator apply for a COC for this research study? No Yes Note: For research not funded by NIH, the IRB may require a COC if the research is collecting personally identifiable information and the information is sensitive and/or the research is collecting information that if disclosed could significantly harm or damage the subject. 23.11 What steps will be taken to protect subjects’ privacy interests? (Check all that apply.) Identification and recruitment of potential subjects follows procedures consistent with privacy standards Consent discussion and research interventions will take place in a private setting Limiting the information being collected to only the minimum amount of data necessary to accomplish the research purposes Limiting the people with access to the identifiable research data to the minimum necessary as specified in the application and consent process Other – Specify: \\[Type protocol text here\\] 23.12 What is the process for ensuring correctness of data entry? Double data entry to reduce risk of errors Electronic edit checks to ensure data being entered are not obviously incorrect Random internal quality and assurance checking of research data Direct entry by subjects Other - Specify: \\[Type protocol text here\\] 23.13 Does this research involve the generation of large-scale human genomic data as defined in NIH Genomic Data Sharing Policy (http://gds.nih.gov)? No Yes – describe the plan for de-identifying the dataset before sharing it with NIH-designated data repositories. \\[Type protocol text here\\] Note: Data sharing with an NIH-designated data repository may require execution of an institutional certificate. Please review the ‘Institutional Certification for NIH Genomic Data Sharing’ section of the Investigator’s Manual for information about seeking institutional certification. 23.14 Does this research involve transfer or disclosure of data and/or specimens to and/or from Penn State? No - skip the remainder of section 22.14 Yes - answer the following questions: Check all that apply: 22.14.1 Data are being transferred or disclosed to Penn State What is the name of the third party(ies) (the institution, sponsor, etc.) sending or providing the data? \\[Type protocol text here\\] Is the third party requiring us to sign a contract regarding the data? 22.14.1.1 Yes - this contract must go through the Office of Sponsored Programs https://www.research.psu.edu/osp/overview-pages/data-use-agreements 22.14.1.2 No 22.14.2 Data are being transferred or disclosed from Penn State What is the name(s) of the third party(ies) (the institution, sponsor, etc.) receiving or accessing the data? \\[Type protocol text here\\] Note: Data transfers or disclosures may require a Data Use Agreement (DUA). 22.14.3 Specimens are being transferred to Penn State What is the name(s) of the third party(ies) (the institution, sponsor, etc.) sending the specimens? \\[Type protocol text here\\] 22.14.4 Specimens are being transferred from Penn State What is the name(s) of the third party(ies) (the institution, sponsor, etc.) receiving the specimens? \\[Type protocol text here\\] Note: All material transfers, either sending or receiving, require a Material Transfer Agreement (MTA). Please contact the Office of Technology Management for more information. 23.14.1 22.14.5 Describe how the data/specimens will be securely transferred or disclosed to/from the third party(ies). \\[Type protocol text here\\] 23.14.2 22.14.6 How are the research data/specimens being transferred from and/or sent to the third party(ies)? Complete the appropriate section(s) and check all that apply within each completed section. 23.14.2.1 23.14.2.2 22.14.6.1 Data being transferred or disclosed to Penn State: Data are being received in aggregate/metrics (just counts, no individual data) De-identified individual data are being received and there is no linking list at either institution (no identifiers, or links to identifiers, such as code numbers) Coded research data without any identifiers are being received and the linking list remains with the entity sending the data; the recipient of the data will not have access to the linking list Coded research data with identifiers (such as dates and/or any of the identifiers listed in section 22.14.7 aside from Study Code) are being received and the linking list remains with the entity sending the data; the recipient of the data will not have access to the linking list Data with identifiers (such as dates and/or any of the identifiers listed in section 22.14.7) are being received and the linking list remains with the entity sending the data; the recipient of the data will have access to the linking list Data with identifiers along with the linking list are being received Other – Specify: \\[Type protocol text here if box is checked\\] 23.14.2.3 22.14.6.2 Data being transferred or disclosed from Penn State: Data are being sent in aggregate/metrics (just counts, no individual data) De-identified individual data are being sent and there is no linking list at either institution (no identifiers, or links to identifiers, such as code numbers) Coded research data without any identifiers are being sent and the linking list remains with the entity sending the data; the recipient of the data will not have access to the linking list Coded research data with identifiers (such as dates and/or any of the identifiers listed in section 22.14.7 aside from Study Code) are being sent and the linking list remains with the entity sending the data; the recipient of the data will not have access to the linking list Data with identifiers (such as dates and/or any of the identifiers listed in section 22.14.7) are being sent and the linking list remains with the entity sending the data; the recipient of the data will have access to the linking list Data with identifiers along with the linking list are being sent Other – Specify: \\[Type protocol text here if box is checked\\] 23.14.2.4 22.14.6.3 Specimens being transferred or disclosed to Penn State: De-identified specimens are being received and there is no linking list at either institution (no identifiers, or links to identifiers, such as code numbers) Coded specimens without any identifiers are being received and the linking list remains with the entity sending the specimens; the recipient of the specimens will not have access to the linking list Coded specimens with identifiers (such as dates and/or any of the identifiers listed in section 22.14.7 aside from Study Code) are being received and the linking list remains with the entity sending the specimens; the recipient of the specimens will not have access to the linking list Coded specimens with identifiers (such as dates and/or any of the identifiers listed in section 22.14.7) are being received and the linking list remains with the entity sending the specimens; the recipient of the specimens will have access to the linking list Coded specimens with identifiers along with the linking list are being received Other – Specify: \\[Type protocol text here if box is checked\\] 23.14.2.5 22.14.6.4 Specimens being transferred or disclosed from Penn State: De-identified specimens are being sent and there is no linking list at either institution (no identifiers, or links to identifiers, such as code numbers) Coded specimens without any identifiers are being sent and the linking list remains with the entity sending the specimens; the recipient of the specimens will not have access to the linking list Coded specimens with identifiers (such as dates and/or any of the identifiers listed in section 22.14.7 aside from Study Code) are being sent and the linking list remains with the entity sending the specimens; the recipient of the specimens will not have access to the linking list Coded specimens with identifiers (such as dates and/or any of the identifiers listed in section 22.14.7) are being sent and the linking list remains with the entity sending the specimens; the recipient of the specimens will have access to the linking list Coded specimens with identifiers along with the linking list are being sent Other – Specify: \\[Type protocol text here if box is checked\\] 23.14.3 22.14.7 If transferring data/specimens with identifiers to or from Penn State, which of the following identifiers will be included with the data/specimens? Check all that apply: Names Medical record numbers Initials Health plan beneficiary numbers Street address Account numbers City Certificate/license numbers Driver’s License numbers Passport numbers State State ID numbers Zip Codes Vehicle identifiers and serial numbers, including license plate numbers County Device identifiers and serial numbers Geocodes Web Universal Resource Locators (URLs) Precincts Internet Protocol (IP) address numbers All elements of dates (except year) for dates directly related to an individual, including birth date, admission date, discharge date, date of death Biometric identifiers, including finger and voice prints Ages &gt; 89 and all elements of dates (including year) indicative of such age, except that such ages and elements may be aggregated into a single category of age 90 or older Full face photographic images and any comparable images Telephone numbers Any other unique identifying number, characteristic, or code (such as the pathology number) Specify: \\[Type protocol text here if box is checked\\] Fax numbers Study code numbers Electronic mail addresses Master list linking study code numbers to subject(s) Social security numbers Genomic sequence data Other – specify: \\[Type protocol text here if box is checked\\] "],["404.html", "Page not found", " Page not found The page you requested cannot be found (perhaps it was moved or renamed). You may want to try searching to find the page's new location, or use the table of contents to find the page you are looking for. "]]
